SEMABIZ, Inc. | ChosaReport.com

日本と海外の市場調査レポート＆サービスを取り扱っております。

血漿分画市場調査レポート

Plasma Fractionation Market Research Report

Plasma Fractionation Market Research Report Information by Product (Immunoglobulin, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, and Others), by Method (Cryoprecipitation, Chromatography, Ethanol Precipitation, Ultrafiltration, and Others), by Application (Immunology, Neurology, Hematology, Critical Care, Pulmonology, Rheumatology, Hemato-Oncology, and Others), by End User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World)-Forecast to 2030
出版年月2024年7月
ページ数142
価格タイプシングルユーザライセンス
価格USD 4,950
種別英文調査報告書

Report Overview

Global Plasma Fractionation Market Research Report Information by Product (Immunoglobulin, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, and Others), by Method (Cryoprecipitation, Chromatography, Ethanol Precipitation, Ultrafiltration, and Others), by Application (Immunology, Neurology, Hematology, Critical Care, Pulmonology, Rheumatology, Hemato-Oncology, and Others), by End User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World)-Forecast to 2030

血漿分画市場調査レポート : 製品（免疫グロブリン、凝固因子濃縮物、アルブミン、プロテアーゼ阻害剤など）、方法（寒冷沈降、クロマトグラフィー、エタノール沈殿、限外濾過など）、用途［（免疫学、神経学、血液学、救急医療、呼吸器学、リウマチ学、血液学） -腫瘍学、その他］、エンドユーザー（病院およびクリニック、臨床研究研究所、学術研究機関、その他）、地域（北米、ヨーロッパ、アジア太平洋、その他世界） – 2030年までの予測

Market Synopsis

In 2023, the market for induction furnaces was estimated to be worth USD 1919.5 million. According to projections, the induction furnace market will increase at a compound annual growth rate (CAGR) of 5.32% from USD 2021.23 million in 2024 to USD 3059.6 million by 2030. The market for induction furnaces has grown significantly in recent years, and it is expected to continue to grow significantly in the near future due to the increased need for technologically advanced and energy-efficient solutions. Furthermore, the steel and aluminum industries are creating significant demand and increasing manufacturing output, which is propelling the growth of the induction furnace market. Furthermore, a significant portion of the continent’s induction furnace sales are being driven by both large and small-scale induction furnace manufacturers.

The market for induction furnaces is expanding rapidly at the moment, mostly because these cutting-edge metallurgical systems are now incredibly accessible. The metal processing and manufacturing industries have seen a radical change as a result of this degree of accessibility, which has increased demand for induction furnaces. Historically, induction furnaces have been the go-to option for companies in a variety of industries due to their accuracy, efficiency, and environmental friendliness. But what sets apart the present market trend is how remarkably accessible these furnaces are to a variety of industries, from large-scale businesses to nimble startups. Due to this accessibility, small and medium-sized businesses (SMEs) are tremendously benefiting.

Insights on Market Segments

The coreless induction furnace and channel induction furnace segments of the induction furnace market have been divided based on type.

The market has been divided into three segments: Up to 1 Ton, 1-100 Ton, and More Than 100 Ton, based on capacity.

The steel, aluminum, copper, and other end-use industries make up the segments of the induction furnace market.

Regional Perspectives

The North American, European, Asia Pacific, Middle East and Africa, and South American segments of the induction furnace market have been divided based on region. Over the course of the forecast period, the Asia Pacific and Europe regions are expected to lead the induction furnace market. By the end of 2030, it is projected that the target regions will present a cumulative incremental opportunity of USD 769.4 Mn. The induction furnace market is expanding rapidly in the Asia Pacific area. This market’s growth in the area is being fueled by several reasons. First and foremost, Asia Pacific is home to some of the biggest and fastest-growing industrial sectors in the world, such as electronics, steel, and automobile manufacture. Induction furnaces are a desirable option because of the increasing demand for effective and eco-friendly melting and heating solutions brought on by this fast industrialization.

The induction furnace market in North America is expanding steadily due to several factors. Induction furnace demand has been steady due to the region’s robust industrial base, especially in the manufacturing, automotive, and aerospace industries. These furnaces are preferred because of their precise temperature control, low energy consumption, and environmentally benign operation. Furthermore, because induction furnaces use less energy and produce fewer emissions than conventional melting and heating techniques, many businesses have adopted them in response to environmental laws and the growing emphasis on sustainability. The continuous automation and upgrading of production processes has also increased the uptake of induction furnace technology. Innovations are also being seen in the market, as producers concentrate on improving their products and developing new technologies to meet the changing needs of the sector.

Principal Players

Major players in the market include Duca Manufacturing, ZZ Industrial (shanghai) Co., Ltd., Topcast Engineering, Wertli AG, HarbisonWalker International, Marx GmbH & Co. KG, ABP Induction System, Ajax TOCCO Magnethermic Corporation, Electrotherm Limited, Otto Junker, Tenova SPA, Pioneer Furnaces Pvt.Ltd, Saint-Gobain, and FOMET.

Table of Contents

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

1.1 OVERVIEW

1.1.1 MARKET SYNOPSIS

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 LIST OF ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING DEMAND FOR PLASMA-DERIVED MEDICINAL PRODUCTS (PDMPS)

4.2.2 GROWING AWARENESS AND DIAGNOSIS OF RARE DISEASES

4.2.3 RISING GERIATRIC POPULATION ACROSS THE GLOBE

4.3 RESTRAINTS

4.3.1 EMERGENCE OF RECOMBINANT THERAPIES AS AN ALTERNATIVE TO PLASMA-DERIVED MEDICINES

4.4 OPPORTUNITY

4.4.1 GROWING TECHNOLOGICAL ADVANCEMENTS AND INNOVATION

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION AND SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE GLOBAL PLASMA FRACTIONATION MARKET

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT ON KEY PLAYERS

6 GLOBAL PLASMA FRACTIONATION MARKET, BY PRODUCT

6.1 OVERVIEW

6.2 IMMUNOGLOBULIN

6.2.1 INTRAVENOUS IMMUNOGLOBULINS

6.2.2 SUBCUTANEOUS IMMUNOGLOBULINS

6.2.3 OTHERS

6.3 COAGULATION FACTOR CONCENTRATES

6.3.1 FACTOR VII

6.3.2 FACTOR VIII (VON WILLEBRAND FACTOR)

6.3.3 FACTOR IX

6.3.4 PROTHROMBIN COMPLEX CONCENTRATE

6.3.5 FIBRINOGEN CONCENTRATES

6.3.6 FACTOR XIII

6.4 ALBUMIN

6.5 PROTEASE INHIBITORS

6.6 OTHERS

7 GLOBAL PLASMA FRACTIONATION MARKET, BY METHOD

7.1 OVERVIEW

7.2 CRYOPRECIPITATION

7.3 CHROMATOGRAPHY

7.4 ETHANOL PRECIPITATION

7.5 ULTRAFILTRATION

7.6 OTHERS

8 GLOBAL PLASMA FRACTIONATION MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 IMMUNOLOGY

8.3 NEUROLOGY

8.4 HEMATOLOGY

8.5 CRITICAL CARE

8.6 PULMONOLOGY

8.7 RHEUMATOLOGY

8.8 ONCOLOGY

8.9 OTHERS

9 GLOBAL PLASMA FRACTIONATION MARKET, BY END USER

9.1 OVERVIEW

9.2 HOSPITALS & CLINICS

9.3 CLINICAL RESEARCH LABORATORIES

9.4 ACADEMIC INSTITUTES

9.5 OTHERS

10 GLOBAL PLASMA FRACTIONATION MARKET, BY REGION

10.1 OVERVIEW

10.2 NORTH AMERICA

10.2.1 US

10.2.2 CANADA

10.3 EUROPE

10.3.1 GERMANY

10.3.2 FRANCE

10.3.3 UK

10.3.4 ITALY

10.3.5 SPAIN

10.3.6 BELGIUM

10.3.7 REST OF EUROPE

10.4 ASIA-PACIFIC

10.4.1 CHINA

10.4.2 INDIA

10.4.3 JAPAN

10.4.4 SOUTH KOREA

10.4.5 AUSTRALIA

10.4.6 REST OF ASIA-PACIFIC

10.5 REST OF THE WORLD

10.5.1 MIDDLE EAST

10.5.2 AFRICA

10.5.3 LATIN AMERICA

11 COMPETITIVE LANDSCAPE

11.1 OVERVIEW

11.2 COMPETITIVE BENCHMARKING

11.3 MAJOR GROWTH STRATEGY IN THE GLOBAL PLASMA FRACTIONATION MARKET

11.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL PLASMA FRACTIONATION MARKET

11.5 KEY DEVELOPMENT ANALYSIS

11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

11.6.1 PRODUCT APPROVAL

11.6.2 ACQUISITION

11.6.3 EXPANSION

11.7 MAJOR PLAYERS FINANCIAL

11.7.1 SALES (USD Billion), 2023

11.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD Billion), 2023

12 COMPANY PROFILES

12.1 PFIZER, INC

12.1.1 COMPANY OVERVIEW

12.1.2 FINANCIAL OVERVIEW

12.1.3 PRODUCTS OFFERED

12.1.4 KEY DEVELOPMENTS

12.1.5 FINANCIAL OVERVIEW

12.1.6 KEY STRATEGIES

12.2 BIO PRODUCTS LABORATORY LTD

12.2.1 COMPANY OVERVIEW

12.2.2 FINANCIAL OVERVIEW

12.2.3 PRODUCTS OFFERED

12.2.4 KEY DEVELOPMENTS

12.2.5 KEY STRATEGIES

12.3 KEDRION S.P.A

12.3.1 COMPANY OVERVIEWS

12.3.2 FINANCIAL OVERVIEW

12.3.3 PRODUCTS OFFERED

12.3.4 KEY DEVELOPMENTS

12.3.5 KEY STRATEGIES

12.4 ADMA BIOLOGICS, INC

12.4.1 COMPANY OVERVIEWS

12.4.2 FINANCIAL OVERVIEW

12.4.3 PRODUCTS OFFERED

12.4.4 KEY DEVELOPMENTS

12.4.5 KEY STRATEGIES

12.5 JAPAN BLOOD PRODUCTS ORGANIZATION

12.5.1 COMPANY OVERVIEWS

12.5.2 FINANCIAL OVERVIEW

12.5.3 PRODUCTS OFFERED

12.5.4 KEY DEVELOPMENTS

12.5.5 KEY STRATEGIES

12.6 GRIFOLS, S.A.

12.6.1 COMPANY OVERVIEW

12.6.2 FINANCIAL OVERVIEW

12.6.3 PRODUCTS OFFERED

12.6.4 KEY DEVELOPMENTS

12.6.5 SWOT ANALYSIS

12.6.6 KEY STRATEGIES

12.7 TAKEDA PHARMACEUTICAL COMPANY LIMITED

12.7.1 COMPANY OVERVIEW

12.7.2 FINANCIAL OVERVIEW

12.7.3 PRODUCTS OFFERED

12.7.4 KEY DEVELOPMENTS

12.7.5 SWOT ANALYSIS

12.7.6 KEY STRATEGIES

12.8 CSL

12.8.1 COMPANY OVERVIEW

12.8.2 FINANCIAL OVERVIEW

12.8.3 PRODUCTS OFFERED

12.8.4 KEY DEVELOPMENTS

12.8.5 SWOT ANALYSIS

12.8.6 KEY STRATEGIES

12.9 OCTAPHARMA AG

12.9.1 COMPANY OVERVIEW

12.9.2 FINANCIAL OVERVIEW

12.9.3 PRODUCTS OFFERED

12.9.4 KEY DEVELOPMENTS

12.9.5 SWOT ANALYSIS

12.9.6 KEY STRATEGIES

12.10 KM BIOLOGICS

12.10.1 COMPANY OVERVIEW

12.10.2 FINANCIAL OVERVIEW

12.10.3 PRODUCTS OFFERED

12.10.4 KEY DEVELOPMENTS

12.10.5 KEY STRATEGIES

13 APPENDIX

13.1 REFERENCES

13.2 RELATED REPORTS

List of Tables

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 GLOBAL PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2030 (USD Billion)

TABLE 3 GLOBAL PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULIN, BY REGION, 2019–2030 (USD Billion)

TABLE 4 GLOBAL PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULIN, BY TYPE, 2019–2030 (USD Billion)

TABLE 5 GLOBAL PLASMA FRACTIONATION MARKET, FOR INTRAVENOUS IMMUNOGLOBULINS BY REGION, 2019–2030 (USD Billion)

TABLE 6 GLOBAL PLASMA FRACTIONATION MARKET, FOR SUBCUTANEOUS IMMUNOGLOBULINS, BY REGION, 2019–2030 (USD Billion)

TABLE 7 GLOBAL PLASMA FRACTIONATION MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD Billion)

TABLE 8 GLOBAL PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY REGION, 2019–2030 (USD Billion)

TABLE 9 GLOBAL PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2030 (USD Billion)

TABLE 10 GLOBAL PLASMA FRACTIONATION MARKET, FOR FACTOR VII, BY REGION, 2019–2030 (USD Billion)

TABLE 11 GLOBAL PLASMA FRACTIONATION MARKET, FOR FACTOR VIII (VON WILLEBRAND FACTOR), BY REGION, 2019–2030 (USD Billion)

TABLE 12 GLOBAL PLASMA FRACTIONATION MARKET, FOR FACTOR IX, BY REGION, 2019–2030 (USD Billion)

TABLE 13 GLOBAL PLASMA FRACTIONATION MARKET, FOR PROTHROMBIN COMPLEX CONCENTRATE, BY REGION, 2019–2030 (USD Billion)

TABLE 14 GLOBAL PLASMA FRACTIONATION MARKET, FOR FIBRINOGEN CONCENTRATES, BY REGION, 2019–2030 (USD Billion)

TABLE 15 GLOBAL PLASMA FRACTIONATION MARKET, FOR FACTOR XIII, BY REGION, 2019–2030 (USD Billion)

TABLE 16 GLOBAL PLASMA FRACTIONATION MARKET, FOR C ALBUMIN, BY REGION, 2019–2030 (USD Billion)

TABLE 17 GLOBAL PLASMA FRACTIONATION MARKET, FOR PROTEASE INHIBITORS, BY REGION, 2019–2030 (USD Billion)

TABLE 18 GLOBAL PLASMA FRACTIONATION MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD Billion)

TABLE 19 GLOBAL PLASMA FRACTIONATION MARKET, BY METHOD, 2019–2030 (USD Billion)

TABLE 20 GLOBAL PLASMA FRACTIONATION MARKET, FOR CRYOPRECIPITATION, BY REGION, 2019–2030 (USD Billion)

TABLE 21 GLOBAL PLASMA FRACTIONATION MARKET, FOR CHROMATOGRAPHY, BY REGION, 2019–2030 (USD Billion)

TABLE 22 GLOBAL PLASMA FRACTIONATION MARKET, FOR ETHANOL PRECIPITATION, BY REGION, 2019–2030 (USD Billion)

TABLE 23 GLOBAL PLASMA FRACTIONATION MARKET, FOR ULTRAFILTRATION, BY REGION, 2019–2030 (USD Billion)

TABLE 24 GLOBAL PLASMA FRACTIONATION MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD Billion)

TABLE 25 GLOBAL PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019–2030 (USD Billion)

TABLE 26 GLOBAL PLASMA FRACTIONATION MARKET, FOR IMMUNOLOGY, BY REGION, 2019–2030 (USD Billion)

TABLE 27 GLOBAL PLASMA FRACTIONATION MARKET, FOR NEUROLOGY, BY REGION, 2019–2030 (USD Billion)

TABLE 28 GLOBAL PLASMA FRACTIONATION MARKET, FOR HEMATOLOGY, BY REGION, 2019–2030 (USD Billion)

TABLE 29 GLOBAL PLASMA FRACTIONATION MARKET, FOR CRITICAL CARE, BY REGION, 2019–2030 (USD Billion)

TABLE 30 GLOBAL PLASMA FRACTIONATION MARKET, FOR PULMONOLOGY, BY REGION, 2019–2030 (USD Billion)

TABLE 31 GLOBAL PLASMA FRACTIONATION MARKET, FOR RHEUMATOLOGY, BY REGION, 2019–2030 (USD Billion)

TABLE 32 GLOBAL PLASMA FRACTIONATION MARKET, FOR ONCOLOGY, BY REGION, 2019–2030 (USD Billion)

TABLE 33 GLOBAL PLASMA FRACTIONATION MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD Billion)

TABLE 34 GLOBAL PLASMA FRACTIONATION MARKET, BY END USER, 2019–2030 (USD Billion)

TABLE 35 GLOBAL PLASMA FRACTIONATION MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2019–2030 (USD Billion)

TABLE 36 GLOBAL PLASMA FRACTIONATION MARKET, FOR CLINICAL RESEARCH LABORATORIES, BY REGION, 2019–2030 (USD Billion)

TABLE 37 GLOBAL PLASMA FRACTIONATION MARKET, FOR ACADEMIC INSTITUTES, BY REGION, 2019–2030 (USD Billion)

TABLE 38 GLOBAL PLASMA FRACTIONATION MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD Billion)

TABLE 39 GLOBAL: PLASMA FRACTIONATION MARKET, BY REGION, 2019–2030 (USD Billion)

TABLE 40 NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY COUNTRY, 2019–2030 (USD Billion)

TABLE 41 NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2030 (USD Billion)

TABLE 42 NORTH AMERICA: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2030 (USD Billion)

TABLE 43 NORTH AMERICA: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2030 (USD Billion)

TABLE 44 NORTH AMERICA: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2030 (USD Billion)

TABLE 45 NORTH AMERICA: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2030 (USD Billion)

TABLE 46 NORTH AMERICA: PLASMA FRACTIONATION MARKET BY END USER, 2019–2030 (USD Billion)

TABLE 47 US: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2030 (USD Billion)

TABLE 48 US: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2030 (USD Billion)

TABLE 49 US: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2030 (USD Billion)

TABLE 50 US: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2030 (USD Billion)

TABLE 51 US: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2030 (USD Billion)

TABLE 52 US: PLASMA FRACTIONATION MARKET BY END USER, 2019–2030 (USD Billion)

TABLE 53 CANADA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2030 (USD Billion)

TABLE 54 CANADA: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2030 (USD Billion)

TABLE 55 CANADA: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2030 (USD Billion)

TABLE 56 CANADA: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2030 (USD Billion)

TABLE 57 CANADA: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2030 (USD Billion)

TABLE 58 CANADA: PLASMA FRACTIONATION MARKET BY END USER, 2019–2030 (USD Billion)

TABLE 59 EUROPE: PLASMA FRACTIONATION MARKET, BY COUNTRY, 2019–2030 (USD Billion)

TABLE 60 EUROPE: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2030 (USD Billion)

TABLE 61 EUROPE: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2030 (USD Billion)

TABLE 62 EUROPE: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2030 (USD Billion)

TABLE 63 EUROPE: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2030 (USD Billion)

TABLE 64 EUROPE: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2030 (USD Billion)

TABLE 65 EUROPE: PLASMA FRACTIONATION MARKET BY END USER, 2019–2030 (USD Billion)

TABLE 66 GERMANY: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2030 (USD Billion)

TABLE 67 GERMANY: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2030 (USD Billion)

TABLE 68 GERMANY: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2030 (USD Billion)

TABLE 69 GERMANY: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2030 (USD Billion)

TABLE 70 GERMANY: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2030 (USD Billion)

TABLE 71 GERMANY: PLASMA FRACTIONATION MARKET BY END USER, 2019–2030 (USD Billion)

TABLE 72 FRANCE: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2030 (USD Billion)

TABLE 73 FRANCE: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2030 (USD Billion)

TABLE 74 FRANCE: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2030 (USD Billion)

TABLE 75 FRANCE: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2030 (USD Billion)

TABLE 76 FRANCE: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2030 (USD Billion)

TABLE 77 FRANCE: PLASMA FRACTIONATION MARKET BY END USER, 2019–2030 (USD Billion)

TABLE 78 UK: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2030 (USD Billion)

TABLE 79 UK: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2030 (USD Billion)

TABLE 80 UK: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2030 (USD Billion)

TABLE 81 UK: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2030 (USD Billion)

TABLE 82 UK: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2030 (USD Billion)

TABLE 83 UK: PLASMA FRACTIONATION MARKET BY END USER, 2019–2030 (USD Billion)

TABLE 84 ITALY: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2030 (USD Billion)

TABLE 85 ITALY: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2030 (USD Billion)

TABLE 86 ITALY: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2030 (USD Billion)

TABLE 87 ITALY: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2030 (USD Billion)

TABLE 88 ITALY: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2030 (USD Billion)

TABLE 89 ITALY: PLASMA FRACTIONATION MARKET BY END USER, 2019–2030 (USD Billion)

TABLE 90 SPAIN: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2030 (USD Billion)

TABLE 91 SPAIN: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2030 (USD Billion)

TABLE 92 SPAIN: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2030 (USD Billion)

TABLE 93 SPAIN: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2030 (USD Billion)

TABLE 94 SPAIN: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2030 (USD Billion)

TABLE 95 SPAIN: PLASMA FRACTIONATION MARKET BY END USER, 2019–2030 (USD Billion)

TABLE 96 BELGIUM: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2030 (USD Billion)

TABLE 97 BELGIUM: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2030 (USD Billion)

TABLE 98 BELGIUM: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2030 (USD Billion)

TABLE 99 BELGIUM: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2030 (USD Billion)

TABLE 100 BELGIUM: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2030 (USD Billion)

TABLE 101 BELGIUM: PLASMA FRACTIONATION MARKET BY END USER, 2019–2030 (USD Billion)

TABLE 102 REST OF EUROPE: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2030 (USD Billion)

TABLE 103 REST OF EUROPE: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2030 (USD Billion)

TABLE 104 REST OF EUROPE: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2030 (USD Billion)

TABLE 105 REST OF EUROPE: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2030 (USD Billion)

TABLE 106 REST OF EUROPE: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2030 (USD Billion)

TABLE 107 REST OF EUROPE: PLASMA FRACTIONATION MARKET BY END USER, 2019–2030 (USD Billion)

TABLE 108 ASIA-PACIFIC: PLASMA FRACTIONATION MARKET, BY COUNTRY, 2019–2030 (USD Billion)

TABLE 109 ASIA-PACIFIC: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2030 (USD Billion)

TABLE 110 ASIA-PACIFIC: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2030 (USD Billion)

TABLE 111 ASIA-PACIFIC: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2030 (USD Billion)

TABLE 112 ASIA-PACIFIC: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2030 (USD Billion)

TABLE 113 ASIA-PACIFIC: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2030 (USD Billion)

TABLE 114 ASIA-PACIFIC: PLASMA FRACTIONATION MARKET BY END USER, 2019–2030 (USD Billion)

TABLE 115 CHINA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2030 (USD Billion)

TABLE 116 CHINA: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2030 (USD Billion)

TABLE 117 CHINA: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2030 (USD Billion)

TABLE 118 CHINA: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2030 (USD Billion)

TABLE 119 CHINA: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2030 (USD Billion)

TABLE 120 CHINA: PLASMA FRACTIONATION MARKET BY END USER, 2019–2030 (USD Billion)

TABLE 121 INDIA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2030 (USD Billion)

TABLE 122 INDIA: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2030 (USD Billion)

TABLE 123 INDIA: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2030 (USD Billion)

TABLE 124 INDIA: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2030 (USD Billion)

TABLE 125 INDIA: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2030 (USD Billion)

TABLE 126 INDIA: PLASMA FRACTIONATION MARKET BY END USER, 2019–2030 (USD Billion)

TABLE 127 JAPAN: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2030 (USD Billion)

TABLE 128 JAPAN: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2030 (USD Billion)

TABLE 129 JAPAN: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2030 (USD Billion)

TABLE 130 JAPAN: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2030 (USD Billion)

TABLE 131 JAPAN: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2030 (USD Billion)

TABLE 132 JAPAN: PLASMA FRACTIONATION MARKET BY END USER, 2019–2030 (USD Billion)

TABLE 133 SOUTH KOREA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2030 (USD Billion)

TABLE 134 SOUTH KOREA: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2030 (USD Billion)

TABLE 135 SOUTH KOREA: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2030 (USD Billion)

TABLE 136 SOUTH KOREA: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2030 (USD Billion)

TABLE 137 SOUTH KOREA: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2030 (USD Billion)

TABLE 138 SOUTH KOREA: PLASMA FRACTIONATION MARKET BY END USER, 2019–2030 (USD Billion)

TABLE 139 AUSTRALIA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2030 (USD Billion)

TABLE 140 AUSTRALIA: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2030 (USD Billion)

TABLE 141 AUSTRALIA: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2030 (USD Billion)

TABLE 142 AUSTRALIA: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2030 (USD Billion)

TABLE 143 AUSTRALIA: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2030 (USD Billion)

TABLE 144 AUSTRALIA: PLASMA FRACTIONATION MARKET BY END USER, 2019–2030 (USD Billion)

TABLE 145 REST OF ASIA-PACIFIC: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2030 (USD Billion)

TABLE 146 REST OF ASIA-PACIFIC: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2030 (USD Billion)

TABLE 147 REST OF ASIA-PACIFIC: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2030 (USD Billion)

TABLE 148 REST OF ASIA-PACIFIC: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2030 (USD Billion)

TABLE 149 REST OF ASIA-PACIFIC: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2030 (USD Billion)

TABLE 150 REST OF ASIA-PACIFIC: PLASMA FRACTIONATION MARKET BY END USER, 2019–2030 (USD Billion)

TABLE 151 REST OT THE WORLD: PLASMA FRACTIONATION MARKET, BY REGION, 2019–2030 (USD Billion)

TABLE 152 REST OF THE WORLD: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2030 (USD Billion)

TABLE 153 REST OF THE WORLD: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2030 (USD Billion)

TABLE 154 REST OF THE WORLD: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2030 (USD Billion)

TABLE 155 REST OF THE WORLD: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2030 (USD Billion)

TABLE 156 REST OF THE WORLD: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2030 (USD Billion)

TABLE 157 REST OF THE WORLD: PLASMA FRACTIONATION MARKET BY END USER, 2019–2030 (USD Billion)

TABLE 158 MIDDLE EAST: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2030 (USD Billion)

TABLE 159 MIDDLE EAST: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2030 (USD Billion)

TABLE 160 MIDDLE EAST: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2030 (USD Billion)

TABLE 161 MIDDLE EAST: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2030 (USD Billion)

TABLE 162 MIDDLE EAST: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2030 (USD Billion)

TABLE 163 MIDDLE EAST: PLASMA FRACTIONATION MARKET BY END USER, 2019–2030 (USD Billion)

TABLE 164 AFRICA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2030 (USD Billion)

TABLE 165 AFRICA: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2030 (USD Billion)

TABLE 166 AFRICA: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2030 (USD Billion)

TABLE 167 AFRICA: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2030 (USD Billion)

TABLE 168 AFRICA: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2030 (USD Billion)

TABLE 169 AFRICA: PLASMA FRACTIONATION MARKET BY END USER, 2019–2030 (USD Billion)

TABLE 170 LATIN AMERICA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2030 (USD Billion)

TABLE 171 LATIN AMERICA: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2030 (USD Billion)

TABLE 172 LATIN AMERICA: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2030 (USD Billion)

TABLE 173 LATIN AMERICA: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2030 (USD Billion)

TABLE 174 LATIN AMERICA: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2030 (USD Billion)

TABLE 175 LATIN AMERICA: PLASMA FRACTIONATION MARKET BY END USER, 2019–2030 (USD Billion)

TABLE 176 MAJOR PLAYERS IN THE GLOBAL PLASMA FRACTIONATION MARKET

TABLE 177 BENCHMARKING OF MAJOR COMPETITORS

TABLE 178 MOST ACTIVE PLAYER IN THE GLOBAL PLASMA FRACTIONATION MARKET

TABLE 179 PRODUCT APPROVAL

TABLE 180 ACQUISITION

TABLE 181 EXPANSION

TABLE 182 PFIZER, INC: PRODUCTS OFFERED

TABLE 183 PFIZER, INC.: KEY DEVELOPMENTS

TABLE 184 BIO PRODUCTS LABORATORY LTD: PRODUCTS OFFERED

TABLE 185 KEDRION S.P.A: PRODUCTS OFFERED

TABLE 186 KEDRION S.P.A: KEY DEVELOPMENTS

TABLE 187 ADMA BIOLOGICS, INC: PRODUCTS OFFERED

TABLE 188 ADMA BIOLOGICS, INC: KEY DEVELOPMENTS

TABLE 189 JAPAN BLOOD PRODUCTS ORGANIZATION: PRODUCTS OFFERED

TABLE 190 GRIFOLS, S.A.: PRODUCTS OFFERED

TABLE 191 GRIFOLS, S.A.: KEY DEVELOPMENTS

TABLE 192 TAKEDA PHARMACEUTICAL COMPANY LIMITED: PRODUCTS OFFERED

TABLE 193 TAKEDA PHARMACEUTICAL COMPANY LIMITED: KEY DEVELOPMENTS

TABLE 194 CSL: PRODUCTS OFFERED

TABLE 195 CSL: KEY DEVELOPMENTS

TABLE 196 OCTAPHARMA AG: PRODUCTS OFFERED

TABLE 197 OCTAPHARMA AG: KEY DEVELOPMENTS

TABLE 198 KM BIOLOGICS: PRODUCTS OFFERED

List of Figures

LIST OF FIGURES

FIGURE 1 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 2 MARKET DYNAMICS: GLOBAL PLASMA FRACTIONATION MARKET

FIGURE 3 DRIVER IMPACT ANALYSIS

FIGURE 4 RESTRAINT IMPACT ANALYSIS

FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL PLASMA FRACTIONATION MARKET

FIGURE 6 PORTER’S FIVE FORCES ANALYSIS: GLOBAL PLASMA FRACTIONATION MARKET

FIGURE 7 GLOBAL PLASMA FRACTIONATION MARKET, PRODUCT SEGMENT ATTRACTIVENESS, 2019-2030 (USD Billion)

FIGURE 8 GLOBAL PLASMA FRACTIONATION MARKET, BY PRODUCT, 2024 & 2030 (USD Billion)

FIGURE 9 GLOBAL PLASMA FRACTIONATION MARKET SHARE (%), BY PRODUCT, 2023

FIGURE 10 GLOBAL PLASMA FRACTIONATION MARKET, METHOD SEGMENT ATTRACTIVENESS, 2019-2030 (USD Billion)

FIGURE 11 GLOBAL PLASMA FRACTIONATION MARKET, BY METHOD, 2024 & 2030 (USD Billion)

FIGURE 12 GLOBAL PLASMA FRACTIONATION MARKET SHARE (%), BY METHOD, 2023

FIGURE 13 GLOBAL PLASMA FRACTIONATION MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2019-2030 (USD Billion)

FIGURE 14 GLOBAL PLASMA FRACTIONATION MARKET, BY APPLICATION, 2024 & 2030 (USD Billion)

FIGURE 15 GLOBAL PLASMA FRACTIONATION MARKET SHARE (%), BY APPLICATION, 2023

FIGURE 16 GLOBAL PLASMA FRACTIONATION MARKET, END USER SEGMENT ATTRACTIVENESS, 2019-2030 (USD Billion)

FIGURE 17 GLOBAL PLASMA FRACTIONATION MARKET, BY END USER, 2024 & 2030 (USD Billion)

FIGURE 18 GLOBAL PLASMA FRACTIONATION MARKET SHARE (%), BY END USER, 2023

FIGURE 19 GLOBAL: PLASMA FRACTIONATION MARKET, BY REGION, 2024 & 2030 (USD Billion)

FIGURE 20 GLOBAL: PLASMA FRACTIONATION MARKET SHARE (%), BY REGION, 2023

FIGURE 21 NORTH AMERICA MARKET ANALYSIS: PLASMA FRACTIONATION MARKET, 2019-2030 (USD Billion)

FIGURE 22 NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY COUNTRY, 2024 & 2030 (USD Billion)

FIGURE 23 NORTH AMERICA: PLASMA FRACTIONATION MARKET SHARE (%), BY COUNTRY, 2023

FIGURE 24 EUROPE MARKET ANALYSIS: PLASMA FRACTIONATION MARKET, 2019-2030 (USD Billion)

FIGURE 25 EUROPE: PLASMA FRACTIONATION MARKET, BY COUNTRY, 2024 & 2030 (USD Billion)

FIGURE 26 EUROPE: PLASMA FRACTIONATION MARKET SHARE (%), BY COUNTRY, 2023

FIGURE 27 ASIA-PACIFIC MARKET ANALYSIS: PLASMA FRACTIONATION MARKET, 2019-2030 (USD Billion)

FIGURE 28 ASIA-PACIFIC: PLASMA FRACTIONATION MARKET, BY COUNTRY, 2024 & 2030 (USD Billion)

FIGURE 29 ASIA-PACIFIC: PLASMA FRACTIONATION MARKET SHARE (%), BY COUNTRY, 2023

FIGURE 30 REST OF THE WORLD MARKET ANALYSIS: PLASMA FRACTIONATION MARKET, 2019-2030 (USD Billion)

FIGURE 31 REST OT THE WORLD: PLASMA FRACTIONATION MARKET, BY REGION, 2024 & 2030 (USD Billion)

FIGURE 32 REST OT THE WORLD: PLASMA FRACTIONATION MARKET SHARE (%), BY REGION, 2023

FIGURE 33 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL PLASMA FRACTIONATION MARKET

FIGURE 34 GLOBAL PLASMA FRACTIONATION MARKET: COMPETITIVE LANDSCAPE

FIGURE 35 MAJOR PLAYERS SALES (USD Billion), 2023

FIGURE 36 MAJOR PLAYER R&D EXPENDITURE (USD Billion), 2023

FIGURE 37 PFIZER, INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 38 PFIZER, INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 39 KEDRION S.P.A: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 40 ADMA BIOLOGICS, INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 41 GRIFOLS, S.A.:FINANCIAL OVERVIEW SNAPSHOT

FIGURE 42 GRIFOLS, S.A.: SWOT ANALYSIS

FIGURE 43 TAKEDA PHARMACEUTICAL COMPANY LIMITED: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 44 TAKEDA PHARMACEUTICAL COMPANY LIMITED: SWOT ANALYSIS

FIGURE 45 CSL: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 46 CSL: SWOT ANALYSIS

FIGURE 47 OCTAPHARMA AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 48 OCTAPHARMA AG: SWOT ANALYSIS

医療・医薬の最新記事8件